Drawing for DYMIND

USPTO serial 79251999

DYMIND

Reviewed by CopyMark Law Group

Reg. 5986739Status 706Registered
Filing date
Status date
Registration date
Feb 18, 2020
Examiner
SPRUILL, DARRYL M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DYMIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DR MATTHIAS SCHOLL ESQ

1321 UPLAND DR. SUITE 1319HOUSTON, TX 77043-4718United States

Goods and services

ClassDescriptionStatusFirst use
005[ Chemical preparations for the diagnosis of pregnancy; ] chemical reagents for medical or veterinary purposes; chemical preparations for medical purposes, namely, reagents for hematology analysis for medical purposes, reagents for blood analysis for medical purposes, reagents for immunoassay testing for medical purposes, reagents for coagulation analyzer and hemostasis testing for medical purposes, reagents for urinalysis testing for medical purposes, [ reagents for molecular diagnostics testing for medical purposes, reagents for diabetes reagents testing for medical purposes, ] reagents for blood gas testing for medical purposes, [ reagents for drug testing for medical purposes, ] reagents for blood typing testing for medical purposes, glycosylated hemoglobin analyzer and reagents testing for medical purposes, diluents for immunoassay for medical purposes, medical diagnostic reagents and solutions, namely, lysing solutions and reagents and hemolytic lysing solutions and reagents, sheath solutions for medical or clinical diagnostic use, medical diagnostic reagents and solutions, namely, sheath solutions, reference control reagents for medical use, chemical reference materials for medical use, cleansing solutions for medical purposes; veterinary preparations, namely, reagents for hematology analysis for veterinary purposes, reagents for blood analysis for veterinary purposes, reagents for immunoassay testing for veterinary purposes, reagents for coagulation analyzer and hemostasis testing for veterinary purposes, reagents for urinalysis testing for veterinary purposes, [ reagents for molecular diagnostics testing for veterinary purposes,] reagents for diabetes reagents testing for veterinary purposes, reagents for blood gas testing for veterinary purposes, [ reagents for drug testing for veterinary purposes,] reagents for blood typing testing for veterinary purposes, diluents for immunoassay for veterinary purposes, medical diagnostic reagents and solutions, namely, lysing solutions and reagents and hemolytic lysing solutions and reagents, sheath solutions for clinical diagnostic use, medical diagnostic reagents and solutions, namely, sheath solutions, reference control reagents for veterinary purposes use, chemical reference materials for veterinary purposes use, cleansing solutions for veterinary purposes; [ biological preparations for medical purposes, namely, cultures of microorganisms for medical purposes, sanitary sterilizing preparations for medical purposes, blood depuratives for medical purposes; diagnostic biomarker reagents for medical purposes; chemical preparations for veterinary purposes for treating diseases affecting mammal; ] diagnostic preparations for medical purposes; [ biological preparations for veterinary purposes, namely, cultures of microorganisms for veterinary use, sanitary sterilizing preparations, blood depuratives for medical purposes; diagnostic preparations for veterinary purposes ]ACTIVE—
010Apparatus for use in medical analysis, namely, hematological analyzing apparatus and instruments, blood cell analyzers, reticulocyte analyzing apparatus and instruments, erythrocyte analyzing apparatus and instruments, blood coagulation analyzing apparatus and instruments, platelet aggregation analyzing apparatus and instruments, [ blood pretreatment apparatus and instruments, ] urinalysis apparatus and instruments, urine cell analyzing apparatus and instruments, urinary particle analyzing apparatus and instruments, hematological analyzing apparatus and instruments, blood cell analyzers, reticulocyte analyzing apparatus and instruments, biochemical analyzer, glycated hemoglobin analyzer, immunoassay analyzer, point-of-care testing, blood and specific protein analyzer, blood and saccharification analyzer, blood and blood coagulation analyzer, biochemical and immune analyzer, blood cell and biochemical and immune analyzer; [ apparatus for artificial respiration; ] anaesthetic masks; blood testing apparatus; testing apparatus for medical purposes, namely, hematological analyzing apparatus and instruments, blood cell analyzers, reticulocyte analyzing apparatus and instruments, erythrocyte analyzing apparatus and instruments, blood coagulation analyzing apparatus and instruments, platelet aggregation analyzing apparatus and instruments, blood pretreatment apparatus and instruments, urinalysis apparatus and instruments, urine cell analyzing apparatus and instruments, urinary particle analyzing apparatus and instruments, hematological analyzing apparatus and instruments, blood cell analyzers, reticulocyte analyzing apparatus and instruments, biochemical analyzer, glycated hemoglobin analyzer, immunoassay analyzer, point-of-care testing, blood and specific protein analyzer, blood and saccharification analyzer, blood and blood coagulation analyzer, biochemical and immune analyzer, blood cell and biochemical and immune analyzer; respirators for artificial respiration; [ pumps for medical purposes, namely, vacuum, pumps for medical purposes, injector; ] hemocytometers, namely, cell counters, blood cell counters, platelet counters, particle counters for medical purposes, [ urine pretreatment apparatus and instruments, apparatus and instruments for clinical chemistry analyzing, bacteria analyzing apparatus and instruments, diluting apparatus and instruments, blood collecting devices, blood sampling tubes, smear test sample making apparatus and instruments; ] medical apparatus and instruments, namely, in vitro diagnostic equipment, [ respiratory equipment, bedside test equipment, medical sewage treatment equipment; ] diagnostic apparatus for medical purposes, namely, diagnostic apparatus for blood analysis, diagnostic apparatus for medical use in urine analysis, bacteria analysis, chemical analysis, body fluid analysis, biological analysis, and enzyme analysis, testing apparatus for medical purposes, namely, [ skin allergy testing apparatus, ] blood glucose testing apparatus, and blood testing apparatus [ , thermometers for medical purposes ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 19, 202671AGREGISTERED-SEC.71 ACCEPTED—
Mar 23, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 28, 2025ES71TEAS SECTION 71 RECEIVED—
Feb 18, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 18, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 18, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 18, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 7, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 17, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 17, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
May 18, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 18, 2019ALIEASSIGNED TO LIE—
Sep 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 5, 2019RFNTREFUSAL PROCESSED BY IB—
Mar 15, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 15, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 6, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2019DOCKASSIGNED TO EXAMINER—
Feb 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance